Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks
Allergy2020Vol. 75(11), pp. 2879–2887
Citations Over TimeTop 10% of 2020 papers
Marc A. Riedl, Marcus Maurer, Jonathan A. Bernstein, Aleena Banerji, Hilary Longhurst, H. Henry Li, Peng Lü, James Hao, Salomé Juethner, William R. Lumry, for the HELP Investigators
Abstract
Protection with lanadelumab started from the first dose and continued throughout the entire study period.
Related Papers
- → Preliminary results of a non-interventional single-center study evaluating the efficacy of long-term use of lanadelumab in routine clinical practice in the Russian Federation(2023)2 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)